Search Results for "Breast Pap Test Trial"

11:27 EST 26th January 2015 | BioPortfolio

Original Source: NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versu...

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Blood Test for Breast Cancer

It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early. A team, led by Oxford University scientists, took te...

New Test Predicts Which Early Breast Cancer Will Metastasize

A test that predicts breast cancer metastases may not be too far away. Unlike other panels, this test checks for the three-cell structure found at sites of extravasation. Medscape Medical News

FDA Master Protocol In Metastatic Breast Cancer Likely In The Works

Oct. 21 public workshop cosponsored by prominent oncology groups will discuss international genomically driven trial to test multiple agents in metastatic breast cancer.

Gene Test May Help Predict Return of Early Breast Tumor, Study Says

FRIDAY, Dec. 12, 2014 -- For women who have early breast tumors surgically removed, a new genetic test may help predict the odds of a recurrence, a new study says. The research, presented Friday at th...

Breast cancer imaging surgery world-first

A world-first clinical trial to test new imaging technology that can scan tumours during breast cancer surgery has been launched at Guy's and St Thomas' NHS Foundation Trust in collaboration with King...

Breast Cancer Vaccine Shows Promise in Early Trial

TUESDAY, Dec. 2, 2014 -- An experimental vaccine designed to stop breast cancer in its tracks appeared to be safe in a preliminary trial. Fourteen women with breast cancer that had spread were injecte...

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Dr Arteaga speaks to ecancertv at SABCS 2014 about the results of the International Breast Cancer Intervention Study-I (IBIS-1) trial. The trial found that tamoxifen significantly decreased the inci...

SABCS 2014: IBIS-I trial finds tamoxifen lowered breast cancer rates among high-risk women

After a median of 16 years of following women at high risk for breast cancer, the International Breast Cancer Intervention Study-I (IBIS-I) trial found that tamoxifen significantly decreased the incid...

Matching PubMed Articles

The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.

A self-control, randomized, and open-label clinical trial was performed to test the effects of the unicellular green algae Chlorella and hot water extract supplementation on quality of life (QOL) in p...

Contralateral Prophylactic Mastectomy in the American College of Radiology Imaging Network 6667 Trial: Effect of Breast MR Imaging Assessments and Patient Characteristics.

Purpose To assess which patient and magnetic resonance (MR) imaging factors are associated with the likelihood of contralateral prophylactic mastectomy (CPM) in patients with newly diagnosed breast ca...

A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors.

Breast cancer is the most common cancer in women worldwide. Understanding the biology of this tumor is a prerequisite for selecting an appropriate treatment. Cell cycle alterations are seen in many ca...

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis.

Background. Mammographic breast density is one of the strongest independent risk factors for developing breast cancer. We examined the effect of exemestane and tamoxifen on breast density in Dutch pos...


Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement